Next generation of immune checkpoint therapy in cancer: new developments and challenges.
about
Fusogenic Viruses in Oncolytic ImmunotherapyTim-3 expression and its role in hepatocellular carcinomaImmune-checkpoint inhibitors for combating T-cell dysfunction in cancerOn the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor AntibodiesDose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumorsBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsClinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancerTargeting the IDO1 pathway in cancer: from bench to bedside
P2860
Q56971929-9467155E-AE9A-42C8-8150-D4F0B6001CD0Q57476217-1F07E889-29F8-4124-9BBB-FD5C90142B8AQ57483931-0987481B-70A9-4420-BD99-ACF279E8460FQ57492388-45D505E1-474A-4D18-83D0-A463571ECA7DQ58698379-DFE1CD2F-0312-41E2-B53F-F62BE01B5F92Q58713932-73251E75-C0B5-4C90-A535-E92B4FD56881Q58731771-77973C51-574A-46D1-A91B-7514CAFF56C3Q58803138-DF815D91-8C63-4E62-BB4F-4ED80207DADB
P2860
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@en
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@nl
type
label
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@en
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@nl
prefLabel
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@en
Next generation of immune checkpoint therapy in cancer: new developments and challenges.
@nl
P2093
P2860
P1476
Next generation of immune checkpoint therapy in cancer: new developments and challenges
@en
P2093
Aixa E Soyano
Bhagirathbhai Dholaria
Julian A Marin-Acevedo
Keith L Knutson
Saranya Chumsri
P2860
P2888
P356
10.1186/S13045-018-0582-8
P50
P577
2018-03-15T00:00:00Z
P6179
1101542748